Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data.
about
The Danish National Database for Asthma: establishing clinical quality indicatorsUsing decision support for population tracking of adherence to recommended asthma guidelinesAssessing asthma severity based on claims data: a systematic review.The use of electronic alerts in primary care computer systems to identify the over-prescription of short-acting beta2-agonists in people with asthma: a protocol for a systematic review.Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients.Identifying the components of asthma health status in children with mild to moderate asthma.Disparities in asthma medication dispensing patterns: the case of pediatric asthma in Puerto Rico.Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study.Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system.Predicting asthma exacerbations in childrenValidity of diagnostic codes and laboratory tests of liver dysfunction to identify acute liver failure events.Long-term Outcomes After Stepping Down Asthma Controller Medications: A Claims-Based, Time-to-Event AnalysisEffectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands.'The blue one takes a battering' why do young adults with asthma overuse bronchodilator inhalers? A qualitative study.Predictors of asthma medication nonadherence.Relationship between recent short-acting beta-agonist use and subsequent asthma exacerbationsPragmatic research and outcomes in asthma and COPDInteracting effects of obesity, race, ethnicity and sex on the incidence and control of adult-onset asthma.Increased asthma risk and asthma-related health care complications associated with childhood obesity.Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids.Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs.The sustainability of a community pharmacy intervention to improve the quality use of asthma medication.Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States.Determination of asthma control using administrative data regarding short-acting beta-agonist inhaler purchase.The relationship between asthma, asthma control and economic outcomes in the United States.Development and preliminary validation of the Asthma Intensity Manifestations Score (AIMS) derived from Asthma Control Test, FEV(1), fractional exhaled nitric oxide, and step therapy assessments.Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status.Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors.Association of exhaled nitric oxide to asthma burden in asthmatics on inhaled corticosteroids.The national burden of poorly controlled asthma, school absence and parental work loss among school-aged children in the United States.Estimating asthma control questionnaire (ACQ) scores from claims data.A computerized surveillance system for asthma.Asthma severity categorization using a claims-based algorithm or pulmonary function testing.Costs and resource use of mild persistent asthma patients initiated on controller therapy.
P2860
Q28074257-AF2F649F-1286-4A6B-A177-E2A8AD705A5EQ28657963-6718D95F-CD02-450E-BE80-37F6971802F3Q31051043-D623F304-0180-49D5-BB3D-2C27C0BE35F6Q33698672-78FAB25A-791F-4872-BCFE-FFED84FBEAE6Q33987564-BA69C840-EED7-40BB-B162-C98A085FAFBEQ34562958-A18A638A-2DF2-459A-A832-1F03EDD359E0Q35058242-4DC7509F-0CEE-4B04-9885-E5A855B79EC9Q35216441-B0013BA0-C2B6-40F3-BD47-37799C744DFEQ35655664-88E8856F-1C11-4CE9-ADD0-84A51A21C7B3Q35811718-FD7AABAD-20D3-4090-8BD2-FF7E2FB4B8B5Q35872008-A6FEF3CA-1B19-4533-B188-18794F28AE4DQ36015448-BD19D256-53BC-4DF5-826A-D2BB12ACFBB2Q36019100-53BB3214-0AD5-48E7-BE13-E7F9517D089FQ36649951-FEA23ABD-F54D-441F-8BE0-9C3596E20269Q36748890-4AC59458-2EE1-4115-877F-163694205E50Q37107385-55EC55EA-348E-4666-BE25-1F5BB31ECB4AQ37300877-0721AB0B-A06C-4D82-AFF9-F9311F847D32Q37349291-18568ADF-DF17-4F91-9F73-550B8247F83DQ37380105-78299FC4-25BA-449A-ADF6-C6D1DFBF835EQ37606269-F80B12C1-65E8-4F3F-A5BC-D7FC232AE7E8Q37766243-44907A54-3F72-4476-87EA-BBA3B5630DD9Q37848882-3B43A86B-228F-465E-BFAA-2331DCEEC1ACQ38443941-F30F8D0C-594A-4540-B5BA-4BBBDFA9B1B1Q38651840-FD6CA9EA-9D16-47C2-86FA-6ED8ADC3E54DQ39209059-942F022D-F6AF-4E8E-8FD2-CF331CEE3647Q39656801-F4E19B77-35AA-4641-BD78-9823CACFE384Q40898783-A8D371B4-041E-40A7-821F-51C6E6B0824FQ41146448-E7332789-94D4-4DDE-B465-42243FB3BC43Q46221607-96BAD6F1-4546-45D2-BD2B-2150FBD35210Q47251279-D39067D1-3406-46DC-B0E5-ECE96A236790Q47662059-6E1A2ABD-C32A-46D3-AC04-3699FF85BD8BQ48566512-B38133C3-4179-47D0-8D79-3DC4E25463EEQ51853060-99F11A5B-D72F-4B0E-A8E8-7783EC62534AQ51887471-8F6CDFBA-A687-41D7-889C-23D73839D51C
P2860
Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Validation of a beta-agonist l ...... om computerized pharmacy data.
@ast
Validation of a beta-agonist l ...... om computerized pharmacy data.
@en
type
label
Validation of a beta-agonist l ...... om computerized pharmacy data.
@ast
Validation of a beta-agonist l ...... om computerized pharmacy data.
@en
prefLabel
Validation of a beta-agonist l ...... om computerized pharmacy data.
@ast
Validation of a beta-agonist l ...... om computerized pharmacy data.
@en
P2093
P1476
Validation of a beta-agonist l ...... om computerized pharmacy data.
@en
P2093
Albin Leong
Andrea J Apter
David Mosen
E Francis Cook
Guillermo Mendoza
Michael S Johnson
Michael Schatz
Thomas B Stibolt
William M Vollmer
P304
P356
10.1016/J.JACI.2006.01.053
P407
P577
2006-03-31T00:00:00Z